Angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers: Is there a difference in response and any advantage to using them together in the treatment of hypertension?

Journal of Clinical Hypertension

Volumn 10, Issue 6, 2008, Pages 489-496

  Moser, Marvin ^a   Rosendorff, Clive ^b   White, William B ^c  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF CONNECTICUT HEALTH CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN 1 RECEPTOR; ANGIOTENSIN 2 RECEPTOR; ANGIOTENSIN II; ANGIOTENSIN RECEPTOR; ANGIOTENSIN RECEPTOR ANTAGONIST; BRADYKININ; CALCIUM ANTAGONIST; CANDESARTAN; CAPTOPRIL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; GLITAZONE DERIVATIVE; LISINOPRIL; LOSARTAN; NITRIC OXIDE; PERINDOPRIL; PLACEBO; PROSTACYCLIN; PROSTAGLANDIN; RAMIPRIL; TELMISARTAN; TRANDOLAPRIL; VALSARTAN;

ANGIONEUROTIC EDEMA; ANTIHYPERTENSIVE ACTIVITY; ARTICLE; CARDIOVASCULAR RISK; CLINICAL TRIAL; COMBINATION CHEMOTHERAPY; CONGESTIVE HEART FAILURE; COUGHING; DIZZINESS; DOSE TIME EFFECT RELATION; DRUG EFFECT; DRUG EFFICACY; DRUG HALF LIFE; DRUG RECEPTOR BINDING; DRUG RESPONSE; DRUG TOLERABILITY; HEART FAILURE; HEART PROTECTION; HIGH RISK PATIENT; HUMAN; HYPERKALEMIA; HYPERTENSION; HYPOTENSION; LOW DRUG DOSE; MONOTHERAPY; NONHUMAN; PRIORITY JOURNAL; PROTEINURIA; RENAL PROTECTION; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; TONGUE EDEMA; TONGUE SWELLING; TREATMENT OUTCOME; UREMIA; DRUG COMBINATION;

ANGIOTENSIN II TYPE 1 RECEPTOR BLOCKERS; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; DRUG THERAPY, COMBINATION; HUMANS; HYPERTENSION;

EID: 55249089508     PISSN: 15246175     EISSN: 17517176     Source Type: Journal    
DOI: 10.1111/j.1751-7176.2008.08560.x     Document Type: Article

References (0)